Shorter versus longer whole breast radiation for early-stage breast cancer
Part of Cancer, Skin clinical trials.
This trial compares a 5-day course of whole breast radiation plus a boost to the standard 9-day course for people with early-stage breast cancer who have certain risk factors, such as high-grade tumors or younger age. The goal is to see if the shorter treatment is just as safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and at least 18 years old.
- You have been diagnosed with invasive breast cancer or ductal carcinoma in situ (DCIS) and have had a lumpectomy within the past 84 days.
- Your cancer has not spread to lymph nodes or other parts of the body (stage T0-3, N0, M0).
- You have at least one risk factor, such as a high-grade tumor, being 50 years old or younger, or having certain features like lymphovascular invasion or positive margins.
- You are in generally good health (ECOG score 0-2) and willing to use effective contraception if you could become pregnant.
- You have not had radiation to the chest or chemotherapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests whether a shorter, 3-day course of partial breast radiation after surgery works as well as standard radiation for women with early-stage breast cancer. It may help reduce time in treatment while aiming to keep cancer from coming back in the treated breast area.
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.